DENISE GARRETT: Open Payments
NPI 1801398714 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,328 in 25 payments from 8 companies in 2025. Trend: 2023 $1,721 · 2024 $1,130 · 2025 $1,328
Food & beverage: $1,328
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $366 |
| Axsome Therapeutics, Inc. | 5 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $299 |
| Neurocrine BioSciences, Inc. | 2 | $194 |
| E.R. Squibb & Sons, L.L.C. | 1 | $77 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
| ABBVIE INC. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: Auvelity, FANAPT, CAPLYTA, INGREZZA, COBENFY, HETLIOZ, INVEGA SUSTENNA, VRAYLAR.
Industry payments across TN — which companies pay providers there.
